Acknowledgements
Our work was supported in part by grants of the Swiss National Science Foundation
(grant numbers 32-27781.89, 32-33927.92, 32-39195.93, 32-42387.94, 32-42542.94,
32-42171.94, 32-46782.96, 32-49308.96, 32-53873.98, 32-61578.00, 31-63769.00,
32B0-103669, 32B0-103669, 32B0-119885/1).
Parts of the data were provided
by the NIMH Human Genetics Initiative, with genotypes having been cleaned according
to Zurich standards. The NIMH data and biomaterials were collected in three projects
that participated in the National Institute of Mental Health (NIMH) Schizophrenia
Genetics Initiative. From 1991-97, the Principal Investigators and Co-Investigators
were: Harvard University, Boston, MA, U01 MH46318, Ming T. Tsuang, M.D., Ph.D., D.Sc.,
Stephen Faraone, Ph.D., and John Pepple, Ph.D.; Washington University, St. Louis, MO,
U01 MH46276, C. Robert Cloninger, M.D., Theodore Reich, M.D., and Dragan Svrakic, M.D.;
Columbia University, New York, NY U01 MH46289, Charles Kaufmann, M.D., Dolores Malaspina,
M.D., and Jill Harkavy Friedman, Ph.D.
The normative data used in the inflammation project was gathered with the support of
grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and
the National Arthritis Foundation.
Chromosomal locations used in our projects rely on an integrated genetic-physical map
developed in Zurich with data taken from extended versions of the deCODE, Ensembl and
NCBI maps.
All our current genetic analyses rely on a genetic-physical
map derived from Ensembl Build 105 of September 25, 2021.